These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30556893)

  • 1. Efficacy and safety of dronedarone in patients with amiodarone-induced hyperthyroidism: a clinical study.
    Perrone MA; Babu Dasari J; Intorcia A; Morgagni R; Sergi D; Battaini F; De Lorenzo A; Bernardini S; Merra G; Romeo F
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8502-8508. PubMed ID: 30556893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Switch From Amiodarone to Dronedarone in Patients With Atrial Fibrillation: Results of the ARTEMIS AF Studies.
    Naccarelli GV; Bhatt DL; Camm AJ; Le Heuzey JY; Lombardi F; Tamargo J; Martinez JM; Naditch-Brûlé L;
    J Cardiovasc Pharmacol Ther; 2020 Sep; 25(5):425-437. PubMed ID: 32500725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study.
    Le Heuzey JY; De Ferrari GM; Radzik D; Santini M; Zhu J; Davy JM
    J Cardiovasc Electrophysiol; 2010 Jun; 21(6):597-605. PubMed ID: 20384650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of antiarrhythmic medications on the risk of cardiovascular outcomes in patients with atrial fibrillation and coronary artery disease.
    Wang SR; Huang KC; Lin TT; Chuang SL; Yang YY; Wu CK; Lin LY
    Int J Cardiol; 2024 Aug; 409():132198. PubMed ID: 38782070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation.
    Piccini JP; Hasselblad V; Peterson ED; Washam JB; Califf RM; Kong DF
    J Am Coll Cardiol; 2009 Sep; 54(12):1089-95. PubMed ID: 19744618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dronedarone: a promising alternative for the management of atrial fibrillation.
    Yalta K; Turgut OO; Yilmaz MB; Yilmaz A; Tandogan I
    Cardiovasc Drugs Ther; 2009 Oct; 23(5):385-93. PubMed ID: 19669399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dronedarone for the treatment of atrial fibrillation and atrial flutter.
    Maund E; McKenna C; Sarowar M; Fox D; Stevenson M; Pepper C; Palmer S; Woolacott N
    Health Technol Assess; 2010 Oct; 14(Suppl. 2):55-62. PubMed ID: 21047492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial).
    Page RL; Connolly SJ; Crijns HJ; van Eickels M; Gaudin C; Torp-Pedersen C; Hohnloser SH;
    Am J Cardiol; 2011 Apr; 107(7):1019-22. PubMed ID: 21296333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dronedarone.
    Tamargo J; López-Farré A; Caballero R; Delpón E
    Drugs Today (Barc); 2011 Feb; 47(2):109-33. PubMed ID: 21431100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of dronedarone in patients previously treated with other antiarrhythmic agents.
    Guerra F; Hohnloser SH; Kowey PR; Crijns HJ; Aliot EM; Radzik D; Roy D; Connolly S; Capucci A
    Clin Cardiol; 2014 Dec; 37(12):717-24. PubMed ID: 25470298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefit-risk assessment of dronedarone in the treatment of atrial fibrillation.
    Adlan AM; Lip GY
    Drug Saf; 2013 Feb; 36(2):93-110. PubMed ID: 23329540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety profile of dronedarone in clinical practice. Results of the Magdeburg Dronedarone Registry (MADRE study).
    Said SM; Esperer HD; Kluba K; Genz C; Wiedemann AK; Boenigk H; Herold J; Schmeisser A; Braun-Dullaeus RC
    Int J Cardiol; 2013 Sep; 167(6):2600-4. PubMed ID: 22781508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of dronedarone as a therapeutic option for patients with atrial fibrillation.
    Lee EJ; Kim J
    J Clin Pharm Ther; 2014 Apr; 39(2):112-7. PubMed ID: 24738113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of dronedarone: a review of randomized trials.
    Christiansen CB; Torp-Pedersen C; Køber L
    Expert Opin Drug Saf; 2010 Jan; 9(1):189-99. PubMed ID: 20001756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A placebo-controlled, double-blind, randomized, multicenter study to assess the effects of dronedarone 400 mg twice daily for 12 weeks on atrial fibrillation burden in subjects with permanent pacemakers.
    Ezekowitz MD; Ellenbogen KA; DiMarco JP; Kaszala K; Boddy A; Geba GP; Koren A
    J Interv Card Electrophysiol; 2015 Mar; 42(2):69-76. PubMed ID: 25638303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dronedarone in high-risk permanent atrial fibrillation.
    Connolly SJ; Camm AJ; Halperin JL; Joyner C; Alings M; Amerena J; Atar D; Avezum Á; Blomström P; Borggrefe M; Budaj A; Chen SA; Ching CK; Commerford P; Dans A; Davy JM; Delacrétaz E; Di Pasquale G; Diaz R; Dorian P; Flaker G; Golitsyn S; Gonzalez-Hermosillo A; Granger CB; Heidbüchel H; Kautzner J; Kim JS; Lanas F; Lewis BS; Merino JL; Morillo C; Murin J; Narasimhan C; Paolasso E; Parkhomenko A; Peters NS; Sim KH; Stiles MK; Tanomsup S; Toivonen L; Tomcsányi J; Torp-Pedersen C; Tse HF; Vardas P; Vinereanu D; Xavier D; Zhu J; Zhu JR; Baret-Cormel L; Weinling E; Staiger C; Yusuf S; Chrolavicius S; Afzal R; Hohnloser SH;
    N Engl J Med; 2011 Dec; 365(24):2268-76. PubMed ID: 22082198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dronedarone therapy in atrial fibrillation: a summary of recent controlled trials.
    Duray GZ; Schmitt J; Hohnloser SH
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4 Suppl):19S-23S. PubMed ID: 20472812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dronedarone on cardiovascular events in atrial fibrillation.
    Hohnloser SH; Crijns HJ; van Eickels M; Gaudin C; Page RL; Torp-Pedersen C; Connolly SJ;
    N Engl J Med; 2009 Feb; 360(7):668-78. PubMed ID: 19213680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dronedarone or amiodarone for rhythm control for atrial fibrillation: implications from the DIONYSOS study.
    Pamukcu B; Lip GY
    Expert Opin Pharmacother; 2010 Dec; 11(17):2775-8. PubMed ID: 21050033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dronedarone: a new antiarrhythmic agent for the treatment of atrial fibrillation.
    Garcia D; Cheng-Lai A
    Cardiol Rev; 2009; 17(5):230-4. PubMed ID: 19690474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.